Edwards Lifesciences defeats Austrian bid to review takeover of smaller rival
Edwards Lifesciences’s takeover of JenaValve Technology, an innovative smaller rival, shouldn’t have been reviewed in Austria due to JenaValve’s lack of "significant" national activities, the country’s Supreme Court has ruled. The ruling...To view the full article, register now.
Already a subscriber? Click here to view full article